Next Article in Journal
Reactions of an Isolable Dialkylsilylene with Aroyl Chlorides. A New Route to Aroylsilanes
Next Article in Special Issue
Current Advances of Tubulin Inhibitors in Nanoparticle Drug Delivery and Vascular Disruption/Angiogenesis
Previous Article in Journal
Synthesis and In Vitro Cytotoxic Properties of Polycarbo-Substituted 4-(Arylamino)quinazolines
Article Menu
Issue 10 (October) cover image

Export Article

Open AccessReview
Molecules 2016, 21(10), 1375; doi:10.3390/molecules21101375

Novel Natural Product- and Privileged Scaffold-Based Tubulin Inhibitors Targeting the Colchicine Binding Site

School of Chemistry and Chemical Engineering, Shandong University, Jinan 250100, China
School of Environment, Guangzhou Key Laboratory of Environmental Exposure and Health and Guangdong Key Laboratory of Environmental Pollution and Health, Jinan University, Guangzhou 510632, China
Authors to whom correspondence should be addressed.
Academic Editor: Wei Li
Received: 10 September 2016 / Revised: 10 October 2016 / Accepted: 11 October 2016 / Published: 15 October 2016
(This article belongs to the Special Issue Tubulin Inhibitors)
View Full-Text   |   Download PDF [6545 KB, uploaded 15 October 2016]   |  


Tubulin inhibitors are effective anticancer agents, however, there are many limitations to the use of available tubulin inhibitors in the clinic, such as multidrug resistance, severe side-effects, and generally poor bioavailability. Thus, there is a constant need to search for novel tubulin inhibitors that can overcome these limitations. Natural product and privileged structures targeting tubulin have promoted the discovery and optimization of tubulin inhibitors. This review will focus on novel tubulin inhibitors derived from natural products and privileged structures targeting the colchicine binding site on tubulin. View Full-Text
Keywords: tubulin inhibitors; microtubule dynamics; antimitotic; multidrug resistance tubulin inhibitors; microtubule dynamics; antimitotic; multidrug resistance

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Dong, M.; Liu, F.; Zhou, H.; Zhai, S.; Yan, B. Novel Natural Product- and Privileged Scaffold-Based Tubulin Inhibitors Targeting the Colchicine Binding Site. Molecules 2016, 21, 1375.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top